Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
The Journal of Pathology|June 29, 2021
Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL-8Carlos E de Andrea, María Carmen Ochoa, María Villalba-Esparza, et al.
ILAR Journal|April 11, 2018
Species Identity Supersedes the Dilution Effect Concerning Hantavirus Prevalence at Sites across Texas and MéxicoMatthew T Milholland, Iván Castro-Arellano, Elizabeth Arellano, et al.
Signal Transduction and Targeted Therapy|March 18, 2025
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial resultsAntonin Levy, Daphné Morel, Matthieu Texier, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 28, 2020
Machine-Learning-Based In-Hospital Mortality Prediction for Transcatheter Mitral Valve Repair in the United StatesDagmar F Hernandez-Suarez, Sagar Ranka, Yeunjung Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular TrapsAlvaro Teijeira, Saray Garasa, Maria C Ochoa, et al.
Nature Communications|December 16, 2021
CD137 (4-1BB) costimulation of CD8<sup>+</sup> T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulationItziar Otano, Arantza Azpilikueta, Javier Glez-Vaz, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Artificial intelligence coronary computed tomography, coronary computed tomography angiography using fractional flow reserve, and physician visual interpretation in the per-vessel prediction of abnormal invasive adenosine fractional flow reserveAndrew Chiou, Melody Hermel, Rajbir Sidhu, et al.
Nature Medicine|February 12, 2019
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastomaKurt A Schalper, Maria E Rodriguez-Ruiz, Ricardo Diez-Valle, et al.
Nature Communications|May 15, 2024
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trialsNeil H Segal, Ignacio Melero, Victor Moreno, et al.
The Journal of Clinical Investigation|May 1, 2026
Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancerAlvaro Lopez-Janeiro, José González-Gomariz, Fadi Issa, et al.
Pageof 20